Schedule 13G ownership disclosure
RXI PHARMACEUTICALS
Security class unavailable · CUSIP: 74979C808
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000944809-18-000008
- Form type
- SC 13G
- Filer
- OPKO HEALTH, INC.
- CIK
- CIK 944809
- Filed
- Feb 12, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership